Overview of the Presentation and Updated Management of Sinusitis

Khaled Abdullah S. Alasmari *

University of Tabuk, Saudi Arabia.

Lena Defallah G. Alzahrani

University of Tabuk, Saudi Arabia.

Sultan Suliman Q. Al-ruwaili

University of Tabuk, Saudi Arabia.

Rahaf Naif A. Alenezi

University of Tabuk, Saudi Arabia.

Sarah Fahad M. Bukhari

University of Tabuk, Saudi Arabia.

Sarah Muqbil B. Altmimi

University of Tabuk, Saudi Arabia.

Shaden Akram A. Alanazi

University of Tabuk, Saudi Arabia.

Lama Muaysh M. Aljohani

University of Tabuk, Saudi Arabia.

Alshaymaa Akram A. Alanazi

University of Tabuk, Saudi Arabia.

Afnan Mohammed H. Almutairi

University of Tabuk, Saudi Arabia.

*Author to whom correspondence should be addressed.


Abstract

Acute and chronic sinusitis are common primary care presentations. They are caused by mucosal inflammation, which inhibits mucociliary function of the nose and paranasal sinuses. Because it affects the mucous membranes that line both the nose and the sinuses, the complete medical word for sinusitis is "rhinosinusitis". Sinusitis is usually caused by a viral upper respiratory tract infection, with bacterial sinusitis occurring in about 2% of cases, yet in most cases overall antibiotics are being used and prescribed which is in most part are not needed, and cases often resolves without antibiotics need, most general practitioners rely on clinical findings to make the diagnosis. Watchful waiting and symptom treatment with nasal oxymetazoline, pseudoephedrine, and saline nasal irrigation are recommended. In this paper, we overview the presentation and management of sinusitis.

Keywords: Sinusitis, rhinosinusitis, presentation, management, mucociliary function, nasal oxymetazoline, pseudoephedrine


How to Cite

Alasmari, K. A. S., Alzahrani, L. D. G., Al-ruwaili, S. S. Q., Alenezi, R. N. A., Bukhari, S. F. M., Altmimi, S. M. B., Alanazi, S. A. A., Aljohani, L. M. M., Alanazi, A. A. A. and Almutairi, A. M. H. (2021) “Overview of the Presentation and Updated Management of Sinusitis”, Journal of Pharmaceutical Research International, 33(39A), pp. 23–30. doi: 10.9734/jpri/2021/v33i39A32136.